Xolair
NDC 50242-227 · Genentech, Inc.
Generic nameomalizumab
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)OMALIZUMAB
Strength300 mg/2mL
Pharmacologic classAnti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]
Marketing categoryBLA
Packages
50242-227-01 — 1 SYRINGE, GLASS in 1 CARTON (50242-227-01) / 2 mL in 1 SYRINGE, GLASS
50242-227-55 — 1 SYRINGE, GLASS in 1 CARTON (50242-227-55) / 2 mL in 1 SYRINGE, GLASS
50242-227-86 — 1 SYRINGE, GLASS in 1 CARTON (50242-227-86) / 2 mL in 1 SYRINGE, GLASS
50242-227-99 — 1 SYRINGE, GLASS in 1 CARTON (50242-227-99) / 2 mL in 1 SYRINGE, GLASS
Billed under HCPCS
J2357 — Injection, omalizumab, 5 mg Medicare Part B payment limit (ASP + 6%): $46.59
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50242-040 — omalizumab, 50242-214 — omalizumab, 50242-215 — omalizumab